ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022

Baricitinib vs tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: a prospective, investigational, real-world study.

Botond Lakatos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.